Sunstein Insights
Back to All Publications
Strategies for Pharmaceutical Portfolio & Product Life-Cycle Management In Face of the New U.S. Patent Law
SMi Pharmaceutical Portfolio and Product Life Cycle Management Conference, London, April 2013.
Most Popular
-
Client Alert: Intellectual Property in Russia
-
NFTs – A Novel Challenge For Traders, Investors and Copyright Lawyers
-
What is a COVID-19 Vaccine Intellectual Property Waiver?
-
Google v. Oracle: Supreme Court Holds Copying of Key Part of Java Software, its API, is Fair Use
-
Will NFTs revolutionize patent law?
-
New Restrictions on Exports to Russia: US Technology Embedded in Products Made Overseas
-
It’s Forever: R&B Group’s Trademark Contested by Rival Singers in Both TTAB and Federal Court
Authors
-
Steven A. Abreu
-
Robert M. Asher
-
William Braunlin, Ph.D.
-
Thomas C. Carey
-
Lawrence M. Green
-
Laura Greenberg-Chao
-
Arne Hans, Ph.D.
-
Bryan D. Harrison
-
George J. Jakobsche
-
Peter J. Karol
-
Christopher Lacenere, Ph.D.
-
Joel R. Leeman
-
London K. Lundstrum
-
Odette T. Martins
-
Kevin R. Mosier
-
Timothy M. Murphy
-
Kathryn E. Noll
-
John W. Powell
-
Jay Sandvos
-
Andrew P. Siuta
-
Alexander J. Smolenski, Jr.
-
Katherine W. Soule
-
Sharona H. Sternberg
-
Bruce D. Sunstein
-
Kerry L. Timbers
-
Lisa M. Tittemore
We use cookies to improve your site experience, distinguish you from other users and support the marketing of our services. These cookies may store your personal information. By continuing to use our website, you agree to the storing of cookies on your device. For more information, please visit our Privacy Notice.